Lanzamiento Enero 2027

Ensayo controlado aleatorizado2024Acceso abierto

Effect of Time-Restricted Eating on Circulating Levels of IGF1 and Its Binding Proteins in Obesity: An Exploratory Analysis of a Randomized Controlled Trial

Akasheh RT, Ankireddy A, Gabel K, Ezpeleta M, Lin S, Tamatam CM, Reddy SP, Spring B, Cheng TD, Fontana L, Khan SA, Varady KA, Cienfuegos S, Kalam F

Nutrients · 7 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Organización sin fines de lucro
Breast Cancer Research Foundation
Organización sin fines de lucro
Australian Youth and Health Foundation
Gobierno
National Institutes of Health
Gobierno
Australian NHMRC Investigator
Gobierno
NIH HHS
Subvenciones
Breast Cancer Research Foundation (T32CA193193); Australian Youth and Health Foundation (APP1177797); Breast Cancer Research Foundation (R01DK119783); Breast Cancer Research Foundation (K12HD101373); Australian Youth and Health Foundation (T32CA193193); Australian Youth and Health Foundation (K12HD101373); Breast Cancer Research Foundation (APP1177797); National Institutes of Health (APP1177797); Australian Youth and Health Foundation (R01DK119783); National Institutes of Health (K12HD101373); National Institutes of Health (R01 DK119783); National Institutes of Health (T32CA193193)

Según 5 financiadores declarados y la declaración de financiación del texto completo.

Publicación

Publicado
2024-10-14 · Nutrients · vol. 16 · número 20 · pág. 3476
Editorial
Multidisciplinary Digital Publishing Institute
Citado
10 citas · más que el 89% de estudios similares · 2.4× el promedio de su campo
Referencias
38 trabajos
Acceso
Acceso abierto (revista) · CC-BY
Áreas de investigación
Dietary Effects on Health · Growth Hormone and Insulin-like Growth Factors · Regulation of Appetite and Obesity
Palabras clave
time-restricted eating, insulin-like growth factor I, IGFBP-2, obesity, weight loss, insulin sensitivity, HOMA-IR, leptin, adipokines, 8-isoprostane, inflammation, high-sensitivity C-reactive protein, body composition, cardiovascular risk markers, diabetes risk, aging, cancer risk
MeSH
humans, insulin resistance, obesity, weight loss, insulin-like growth factor i, insulin-like growth factor binding proteins, insulin-like growth factor binding protein 1, insulin-like growth factor binding protein 2, insulin-like growth factor binding protein 3, fasting, body composition, time factors, adult, middle aged, female, male, adipokines, biomarkers

14 autores

  • Rand T. Akasheh🇯🇴🇺🇸 · autor de correspondenciaAmerican University of Madaba; University of Illinois Chicago; The Ohio State University
  • Aparna Ankireddy🇺🇸University of Illinois Chicago
  • Kelsey Gabel🇺🇸University of Illinois Chicago
  • Mark Ezpeleta🇺🇸University of Illinois Chicago
  • Shuhao Lin🇺🇸University of Illinois Chicago
  • Chandra Mohan Tamatam🇺🇸University of Illinois Chicago
  • Sekhar P. Reddy🇺🇸University of Illinois Chicago
  • Bonnie J. Spring🇺🇸Northwestern University
  • Ting‐Yuan David Cheng🇺🇸The Ohio State University
  • Luigi Fontana🇦🇺The University of Sydney; Royal Prince Alfred Hospital
  • Seema Ahsan Khan🇺🇸Northwestern University
  • Krista A Varady🇺🇸University of Illinois Chicago
  • Sofia Cienfuegos🇺🇸University of Illinois Chicago
  • Faiza Kalam🇺🇸Northwestern University; The Ohio State University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Obesity is associated with alterations in circulating IGF1, IGF1-binding proteins (IGFBPs), insulin, inflammatory markers, and hormones implicated in cardiovascular disease, diabetes, cancer, and aging. However, the effects of 4 and 6 h time-restricted eating (TRE) on circulating IGF1 and IGFBPs is uncertain.

Objective

This study aimed to investigate the effects of TRE on plasma IGF1, IGFBP1, IGFBP2, and IGFBP3, and whether these effects were mediated by weight loss or body composition changes. Insulin sensitivity, glucose control, adipokines, and inflammatory markers were also examined.

Design

An exploratory analysis of an 8-week randomized controlled trial implementing a daily TRE intervention was carried out.

Participants/setting

This study was conducted at the University of Illinois at Chicago in 2019. Participants with obesity were randomized to 4 or 6 h TRE (n = 35) or a control (n = 14) group. Plasma biomarkers were measured by ELISA at baseline and week 8. In a sub-analysis, participants were stratified into higher- (>3.5%) and lower- (≤3.5%) weight-loss groups.

Intervention

Participants fasted daily from 7 p.m. to 3 p.m. in the 4 h TRE group (20 h) and from 7 p.m. to 1 p.m. in the 6 h TRE group (18 h), followed by ad libitum eating for the remainder of the day. Controls received no dietary recommendations.

Main outcome measures

IGF1, IGFBPs, hsCRP, and adipokines were the main outcome measures of this analysis.

Statistical analysis

Repeated measures ANOVA and mediation analysis were conducted.

Results

Body weight significantly decreased with TRE (-3.6 ± 0.3%), contrasting with controls (+0.2 ± 0.5%, p < 0.001). Significant effects of TRE over time were observed on plasma IGFBP2, insulin, HOMA-IR, and 8-isoprostane levels, without affecting other biomarkers. In the sub-analysis, IGFBP2 increased while leptin and 8-isoprostane decreased significantly only in the "higher weight loss" subgroup. Changes in insulin and HOMA-IR were related to TRE adherence.

Conclusions

Eight-week daily 4 to 6 h TRE did not affect IGF1, IGFBP1, or IGFBP3 levels but improved insulin, HOMA-IR, and 8-isoprostane. IGFBP2 increased and leptin decreased when weight loss exceeded 3.5% of baseline.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.